Jared C Lewis

Title: **Inventor Profile: Jared C. Lewis**

Introduction

Jared C. Lewis is a notable inventor based in Oakland, California, recognized for his significant contributions to the field of pharmaceuticals. With one patent to his name, he has made advancements that could impact the treatment of eating disorders, weight gain, and obesity.

Latest Patents

Jared holds a patent for "2-Aminoquinolines as Melanin Concentrating Hormone Receptor Antagonists." This innovation relates to compounds that antagonize the effects of melanin-concentrating hormone (MCH) through its receptor, providing therapeutic potential for various metabolic disorders.

Career Highlights

Jared is currently associated with Abbott Laboratories Corporation, a leading global healthcare company committed to innovation. His work focuses on developing novel compounds that address critical health issues related to obesity and eating disorders.

Collaborations

Throughout his career, Jared has collaborated with esteemed colleagues, including Christine Ann Collins and Ju Gao. Together, they contribute to pioneering research that enhances the understanding and treatment of metabolic conditions.

Conclusion

Jared C. Lewis exemplifies the spirit of innovation within the pharmaceutical industry. His patented work on melanin concentrating hormone receptor antagonists underscores his commitment to improving health outcomes, particularly in addressing obesity and related disorders. As he continues his journey at Abbott Laboratories Corporation, his future endeavors are anticipated with great interest.